Bruker Corporation announces novel magnet technology and analytical solutions to support broad adoption of nuclear magnetic resonance, NMR, in academic basic and clinical research, as well as in biopharma drug discovery, development and process analytical technologies, PAT.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR:
